Insiders Autolus Therapeutics plc

Equities

AUTL

US05280R1005

Market Closed - Nasdaq Other stock markets 04:00:00 2024-07-05 pm EDT			5-day change	1st Jan Change
3.45 ^USD	-1.15%		-0.86%	-46.43%

Jul. 03	European Equities Traded in the US as American Depositary Receipts Trend Higher in Wednesday Trading	MT
Jul. 02	European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Autolus Therapeutics plc Appoint Michael Weston Bonney as Director	May. 13	CI
Autolus Therapeutics plc Appoints Ravi Madduri Rao as Director	May. 13	CI
Autolus Therapeutics plc Announces Termination of John Johnson as Director	May. 13	CI
Autolus Therapeutics Appoints Mike Bonney as Chair	Apr. 01	MT
Autolus Therapeutics Announces Changes to its Board of Directors	Apr. 01	CI
Autolus Therapeutics plc Announces Resignation of Edgar Braendle, Chief Development Officer	Mar. 14	CI
BioNTech Agrees To Invest $200 Million in Autolus, Starts Strategic Collaboration	Feb. 08	DJ
Autolus Therapeutics plc Announces the Appointment of Robert W. Azelby to Its Board of Directors	Jan. 10	CI
Autolus Therapeutics plc Announces Changes to Its Board of Directors, Effective December 31, 2023	Dec. 22	CI
Autolus Therapeutics Appoints Robert Dolski Finance Chief	23-07-19	MT
Autolus Therapeutics plc Announces Management Changes	23-07-19	CI
Autolus Therapeutics plc Appoints Robert Iannone as Non-Executive Director	23-06-20	CI
MorphoSys Appoints Lucinda Crabtree as CFO	23-03-14	MT
Autolus Therapeutics' Chief Financial Officer Lucinda Crabtree to Step Down	23-03-14	MT
Autolus Therapeutics plc Announces Resignation of Lucinda Crabtree as Chief Financial Officer	23-03-14	CI
Autolus Therapeutics plc Announces Board Changes	23-01-20	CI
Autolus Therapeutics' CFO To Step Down; Replacement Named	22-01-10	MT
JW Therapeutics Appoints Immunotherapy Expert as Chief Scientific Officer	22-01-10	MT
Autolus Therapeutics plc Announces the Appointment of Dr. William D. Young as A Non-Executive Director with Effect from November 15, 2021	21-11-15	CI
Gain Therapeutics : Names Matthias Alder COO	21-10-19	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Autolus Therapeutics plc

Equities

AUTL

US05280R1005

Insiders

Filters